Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Key Oncologics
Johannesburg, Gauteng, South Africakeyoncologics.co.za ↗
- Ownership
- Private
- Employees
- ~35
- Development stage
- Other
01
Overview
Key Oncologics is a specialized pharmaceutical company based in South Africa that focuses on the marketing and distribution of oncology and hematology products. The company partners with global biotechnology and pharmaceutical firms to bring innovative cancer treatments to the Southern African market. Their portfolio includes a range of chemotherapy agents, targeted therapies, and supportive care medications. Key Oncologics provides comprehensive medical support and education to healthcare professionals to ensure the optimal use of their specialized therapeutic offerings.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeMonoclonal antibodyBiologic
- Industry
- Drug Discovery Services
02
Partnerships
Beyond the preview
Go deeper on Key Oncologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Key Oncologics.